Transit Alert: SEPTA is cutting bus, subway, and rail service across Philadelphia. These changes may affect patients, visitors, and staff traveling to and from Fox Chase Cancer Center locations. Read full update.
Breadcrumb
- Home
- Clinical Care
- Departments
- Clinical Departments
- Hematology/Oncology
- Immunotherapy
- Checkpoint Inhibitors
Checkpoint Inhibitors
Checkpoint inhibitors enable the body’s own immune system to recognize and destroy cancer cells. Immune system T cells are designed to detect and fight infections and diseases like cancer. They attack when they come across a cancer cell. Tumor cell secrete a substance which inhibits the immune system from attacking it, allowing them to thrive. Checkpoint inhibitors disrupt this process, unleashing the T cells on cancer.
Checkpoint inhibitors are used to treat many different cancers, typically those that have metastasized. Among them are melanoma, non-small cell lung cancer, kidney cancer, bladder cancer, Hodgkin's lymphoma, and some head and neck cancers. Checkpoint inhibitors are sometimes combined to boost their power.
Share
-
Share with Facebook
-
Share with twitter
-
Share with email
-
Print this